Search Results - Nicolas Partouche
- Showing 1 - 4 results of 4
-
1
Does the IL-6/KL-6 ratio distinguish different phenotypes in COVID-19 Acute Respiratory Distress Syndrome? An observational study stemmed from prospectively derived clinical, biolo... by Nicolas Partouche, Myriam Maumy, Thien-Nga Chamaraux-Tran, Frederic Bertrand, Francis Schneider, Nicolas Meyer, Morgane Solis, Samira Fafi-Kremer, Eric Noll, Julien Pottecher
Published in PLoS ONE (2025-01-01)Get full text
Article -
2
Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis by Praveen Papareddy, Michael Selle, Nicolas Partouche, Vincent Legros, Benjamin Rieu, Jon Olinder, Cecilia Ryden, Eva Bartakova, Michal Holub, Klaus Jung, Julien Pottecher, Heiko Herwald
Published in Frontiers in Immunology (2024-01-01)Get full text
Article -
3
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia by Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie-Helene Schlageter, Cecile Bally, Elsa Miekoutima, Ramy Rahmé, Jacqueline Lehmann-Che, Lionel Ades, Pierre Fenaux, Bruno Cassinat, Stephane Giraudier
Published in Haematologica (2020-06-01)Get full text
Article -
4
A novel AAV9-dual microRNA-vector targeting GRIK2 in the hippocampus as a treatment for mesial temporal lobe epilepsy by Stéphane J. Baudouin, April R. Giles, Nick Pearson, Severine Deforges, Chenxia He, Céline Boileau, Nicolas Partouche, Andreas Borta, Justine Gautron, Morgane Wartel, Irena Bočkaj, Didier Scavarda, Fabrice Bartolomei, Guillaume Penchet, Jérôme Aupy, Jennifer Sims, Jared Smith, Andrew Mercer, Olivier Danos, Christophe Mulle, Valérie Crépel, Richard Porter
Published in Molecular Therapy: Methods & Clinical Development (2024-12-01)Get full text
Article